Chemical Biology News

  • Founding of Chemical Biology Ventures

    Chemical Biology Ventures (CBV) was formed to provide translational research advice & expertise to academics, biotech & pharma to accelerate the production of new products from world-class science.

    During the last ten-years CBV's founder, Lloyd Czaplewski, built-up an antibacterial R&D business called Prolysis. He was responsible for the core science, portfolio creation, intellectual property, fund-raising & business development - leading to the sale of the business to Biota in 2009.

    Chemical Biology Ventures aims to work with world-class academics, charities, Research Councils, Venture Capital groups and businesses to enhance translational output & impact through the delivery of new products & to maximise the generation of wealth.


Chemical Biology Ventures News

Welcome to Chemical Biology Ventures News

CBV updates & relevant chemical biology papers, news & comments will be posted

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.

Get Flash Player